(Q33883556)

29 July 2017

1 reference

title

Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis (English)

1 reference

29 July 2017

1 reference

1 reference

Shankland SJ

1

1 reference

29 July 2017

Wolf G

series ordinal

2

1 reference

29 July 2017

language of work or name

1 reference

1 April 2000

1 reference

American Journal of Physiology - Renal Physiology

29 July 2017

published in

1 reference

29 July 2017

volume

278

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

F515-29

1 reference

Growth factors in glomerulonephritis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Cyclin D1 is a nuclear protein required for cell cycle progression in G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Radiation-induced cell cycle arrest compromised by p21 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Rat mesangial cell hypertrophy in response to transforming growth factor-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Size control in animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

The many masks of focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Crystal structure of cyclin-dependent kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Cdk inhibitors: on the threshold of checkpoints and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

The biology of renal hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Cellular events in renal hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Cyclin a is required for the onset of DNA replication in mammalian fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

The mechanism and control of cytokinesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Progression of renal disease and renal hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

The glomerular response to injury: progression or resolution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

The progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Cyclin dependent kinase regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Apoptosis and the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Principles of CDK regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Cyclin ubiquitination: the destructive end of mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Cell cycle regulation and differentiation in the human podocyte lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Viewpoint: putting the cell cycle in order

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Animal cell cycles and their control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Universal control mechanism regulating onset of M-phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Cyclin-dependent regulation of G1 in mammalian fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Podocyte loss and progressive glomerular injury in type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

G1 events and regulation of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Temporal expressions of cyclins and cyclin dependent kinases during renal development and compensatory growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Reversible phosphorylation and mitotic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Renal hypertrophy and kidney disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

The retinoblastoma protein: more than a tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Cell-cycle control and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Cyclin E-CDK2 is a regulator of p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

G1 phase progression: cycling on cue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Inhibitors of mammalian G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Regeneration after acute tubular necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

The retinoblastoma protein and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Changing concepts of compensatory renal growth: from humoral pathology to molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Molecular mechanisms of diabetic renal hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.2000.278.4.F515

10.1152/AJPRENAL.2000.278.4.F515

21 January 2018

Identifiers

DOI

0 references

1 reference